PIB’S BULLETIN ON COVID-19
PIB Headquarters
Posted On:
19 APR 2022 5:45PM by PIB Delhi
|
#Unite2FightCorona #IndiaFightsCorona
Press Information Bureau
Ministry of Information & Broadcasting
Government of India
*****
India’s Cumulative COVID-19 Vaccination Coverage exceeds 186.72 Cr
Over 2.47 Cr 1st dose vaccines administered for age group 12-14 years
India’s Active caseload currently stands at 11,860
1,247 new cases reported in the last 24 hours
Recovery Rate currently stands at 98.76%
Weekly Positivity Rate is presently at 0.34%
India’s COVID-19 vaccination coverage has exceeded 186.72 Cr (1,86,72,15,865) as per provisional reports till 7 am today. This has been achieved through 2,27,79,246 sessions.
COVID-19 vaccination for the age group 12-14 years was started on 16 March, 2022. So far, more than 2.47 Cr (2,47,06,692) adolescents have been administered with the first dose of COVID-19 vaccine. Similarly, the COVID-19 precaution dose administration for age group 18-59 years also started from 10th April, 2022 onwards. 1,85,860 precaution doses have been administered so far.
The break-up of the cumulative figure as per the provisional report till 7 am today include:
Cumulative Vaccine Dose Coverage |
||
HCWs |
1st Dose |
10404423 |
2nd Dose |
10009004 |
|
Precaution Dose |
4614590 |
|
FLWs |
1st Dose |
18414423 |
2nd Dose |
17527063 |
|
Precaution Dose |
7174576 |
|
Age Group 12-14 years |
1st Dose |
24706692 |
2nd Dose |
469519 |
|
Age Group 15-18 years |
1st Dose |
57928041 |
2nd Dose |
40600205 |
|
Age Group 18-44 years |
1st Dose |
555304803 |
2nd Dose |
473277032 |
|
Precaution Dose |
41778 |
|
Age Group 45-59 years |
1st Dose |
202857576 |
2nd Dose |
186912781 |
|
Precaution Dose |
144082 |
|
Over 60 years |
1st Dose |
126818941 |
2nd Dose |
116427786 |
|
Precaution Dose |
13582550 |
|
Precaution Dose |
2,55,57,576 |
|
Total |
1,86,72,15,8 |
India’s Active Caseload currently stands at 11,860. Active cases now constitute 0.03% of the country’s total Positive Cases.
Consequently, India’s recovery rate stands at 98.76%. 928 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,25,11,701.
1,247 new cases were reported in the last 24 hours.
The last 24 hours saw a total of 4,01,909 COVID-19 tests being conducted. India has so far conducted over 83.25 Cr (83,25,06,755) cumulative tests.
Weekly Positivity Rate in the country currently stands at 0.34% and the Daily Positivity rate is also reported to be 0.31%.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1817923
Update on COVID-19 Vaccine Availability in States/UTs
More than 192.27 Crore vaccine doses provided to States/UTs
More than 20.52 Crore balance and unutilized vaccine doses still available with States/UTs
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
VACCINE DOSES |
(As on 19th April 2022) |
SUPPLIED |
1,92,27,23,625 |
BALANCE AVAILABLE |
20,52,07,261 |
More than 192.27 crore (1,92,27,23,625) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through direct state procurement category.
More than 20.52 Cr (20,52,07,261) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1817915
“Pradhan Mantri Garib Kalyan Package: Insurance Scheme for Health Workers fighting COVID-19” extended for a further period of 180 days
The ‘Pradhan Mantri Garib Kalyan Package (PMGKP), insurance scheme for Health Care Workers Fighting COVID-19’ has been extended for a further period of 180 days from 19th April, 2022. It has been decided to extend the policy so as to continue to provide the safety net to the dependents of health workers who are deputed to take care of COVID-19 patients.
A letter dt. 19th April 2022 to this effect has been issued to the Additional Chief Secretaries (Health)/Principal Secretaries (Health)/ Secretaries (Health) of all States/UTs for giving wide publicity amongst the health workers in their respective States/UTs.
The PMGKP was launched on 30th March, 2020 to provide comprehensive personal accident cover of Rs. 50 Lakh to 22.12 lakh health care providers including community health workers and private health workers who may have been in direct contact and care of COVID-19 patients and may be at risk of being impacted by this.
For details:- https://pib.gov.in/PressReleasePage.aspx?PRID=1817977
Plasma-based green disinfectants can limit spread of infectious diseases like
COVID 19
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for COVID 19.
The COVID 19 pandemic had brought forth the urgent need for decontaminants that can limit the spread of infectious diseases through contact. However, most decontaminants consisted of chemicals which are hazardous for the environment. This encouraged researchers to work towards greener alternatives.
A team of scientists Dr. Kamatchi Sankaranarayanan, Dr. Mojibur R. Khan, and Dr. H. Bailung from the Life Sciences and Physical Sciences divisions from the Institute of the Advanced Study in Science and Technology (IASST), an autonomous research Institute of the Department of Science and Technology (DST), Govt. of India, Guwahati, Assam has demonstrated that the plasma generated by cold atmospheric pressure (CAP) has the potential to deactivate SARS-CoV-2 spike protein, which binds to human ACE2 receptor for inducing viral infection and subsequent Covid-19.
Plasma, the fourth state of matter which makes up most of the universe when produced in controlled conditions in the lab and are termed as Cold Atmospheric Pressure Plasma (CAP). The scientists passed plasma forming gases such as Helium, Argon, and Air through a high voltage electric field which led to the formation of a stable plasma with a mixture of ions, and electrons emitting a pink glow of CAP inside the reaction chamber.
For details:- https://pib.gov.in/PressReleasePage.aspx?PRID=1818089
****
AS